68 results
8-K
EX-10.1
v9gg11
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K/A
EX-10.1
nj9zkjw ew1huxe0l
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
tuoxc
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
S-8
EX-99.1
mjtckyxdnj7amb0
9 Jun 23
Registration of securities for employees
5:19pm
8-K
EX-99.1
3vumc8zz7pnqds0i
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
jzu3mum
7 Nov 22
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
0tolm6nlhy6w98hh
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
424B4
lqrgjad4wjdvrhq b2
5 Jul 22
Prospectus supplement with pricing info
4:26pm
424B5
g14 xosk5
27 Apr 22
Prospectus supplement for primary offering
6:30am